Table 2.
Baseline characteristics of propensity-matched men and women undergoing isolated tricuspid valve surgery from 2004 to 2013
| Men (n=366) |
Women (n=366) |
P value |
|
| Age, mean±SD | 57.9±18.1 | 57.6±17.2 | 0.86 |
| Race, n (%) | |||
| Caucasian | 212 (57.9) | 217 (59.3) | 0.88 |
| African American | 36 (9.8) | 35 (9.6) | |
| Hispanic | 22 (6.0) | 18 (4.9) | |
| Teaching hospital, n (%) | 314 (85.8) | 315 (86.1) | 0.99 |
| Medical comorbidity, n (%) | |||
| Hypertension | 175 (47.8) | 171 (46.7) | 0.82 |
| Diabetes | 66 (18.0) | 68 (18.6) | 0.92 |
| Coronary artery disease | 126 (34.4) | 122 (33.3) | 0.80 |
| Atrial fibrillation/flutter | 180 (49.2) | 175 (47.8) | 0.76 |
| History of permanent pacemaker/ICD | 45 (12.3) | 36 (9.8) | 0.35 |
| Pulmonary hypertension | 81 (22.1) | 86 (23.5) | 0.72 |
| Chronic pulmonary disease | 56 (15.3) | 54 (14.8) | 0.92 |
| Anaemia | 67 (18.3) | 71 (19.4) | 0.77 |
| Chronic kidney disease | 71 (19.4) | 71 (19.4) | 0.99 |
| End-stage renal disease | 22 (6.0) | 20 (5.5) | 0.86 |
| Liver disease | 24 (6.6) | 24 (6.6) | 0.99 |
| Charlson comorbidity index ≥2 | 208 (56.8) | 200 (54.6) | 0.56 |
| Prior sternotomy, n (%) | 39 (10.7) | 39 (10.7) | 0.99 |
| Prior valve surgery, n (%) | 22 (6.0) | 32 (8.7) | 0.21 |
| Surgical characteristics, n (%) | |||
| TV replacement—mechanical | 81 (22.1) | 79 (21.6) | 0.93 |
| TV replacement—bioprosthetic | 138 (37.7) | 136 (37.2) | 0.88 |
| TV repair | 147 (40.2) | 151 (41.3) | 0.83 |
| Concomitant CABG | 76 (20.8) | 73 (19.9) | 0.84 |
CABG, coronary artery bypass graft surgery; ICD, implantable cardiac defibrillator; TV, tricuspid valve.